Congenital adrenal hyperplasia classification

Jump to navigation Jump to search

Congenital adrenal hyperplasia main page

Overview

Classification

21-hydroxylase deficiency
11β-hydroxylase deficiency
17 alpha-hydroxylase deficiency
3 beta-hydroxysteroid dehydrogenase deficiency
Cytochrome P450-oxidoreductase (POR) deficiency (ORD)
Lipoid congenital adrenal hyperplasia

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mehrian Jafarizade, M.D [2]

Overview

Classification

Congenital adrenal hyperplasia may be classified in to nine types, based on specified genetic mutation as following:[1]

21-hydroxylase deficiency, genetic defects: CYP21A2. The most common cause of congenital adrenal hyperplasia worldwide, accounting for more than 90 percent of cases, is 21-hydroxylase deficiency.[2]


11β-hydroxylase deficiency, genetic defects: CYP11B1

17α-hydroxylase/ 17,20-lyase deficiency, genetic defects: CYP17A1

3β-hydroxy-steroid dehydrogenase type 2 deficiency,genetic defects: HSD3B2

P450 oxidoreductase deficiency, genetic defects: POR

Hexose-6-phosphate-dehydrogenase deficiency (apparent cortisone reductase deficiency [ACRD])

PAPSS2 deficiency (apparent dehydroepiandrosterone [DHEA] sulfotransferase deficiency

Lipoid adrenal hyperplasia, genetic defects: StAR

Cholesterol side chain cleavage enzyme deficiency, genetic defects: CYP11A1

References

  1. El-Maouche D, Arlt W, Merke DP (2017). "Congenital adrenal hyperplasia". Lancet. doi:10.1016/S0140-6736(17)31431-9. PMID 28576284.
  2. White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.


Template:WikiDoc Sources